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Abstract 
 
Background: Toxoplasma gondii is a widespread zoonotic protozoan that infects approximately one third of the global 
human population and all other warm-blooded animals. The present study aims to evaluate the prophylactic effects of 
Satureja khuzestanica essential oil (SKEO) on infected mice with acute toxoplasmosis.  
Materials and Methods: The components of the SKEO were identified by gas chromatography/mass spectroscopy 
(GC/MS). To evaluate the prophylactic effects of SKEO, mice were divided into four groups. (i) non-treated group, (ii) 
mice treated with olive oil once a day for two weeks, (iii) mice treated with SKEO at the dose of 0.2ml/kg once a day 
for two weeks, (iv) and mice orally treated with SKEO at the dose of 0.3 ml/kg once a day for two weeks. After 24 h 
(fifteenth day) mice in the groups of two-four were infected intraperitonealy with 10-4 tachyzoite of T. gondii, RH 
strain. The mortality rate in all infected mice and the number of tachyzoites from infected mice were recorded.  
Results: The main components of SKEO were carvacrol (78.8%), thymol (7.5%), and beta-Bisabolene (1.2%). 
Findings of prophylactic effects revealed that mortality rate of infected mice was 8 days after oral administration of 
SKEO at the concentration of 0.2 and 0.3ml/kg (P<0.05). In contrast, this value for control group was 5 days. In 
addition, SKEO significantly reduced the mean number of tachyzoites compared with control group (P<0.05). No 
significant difference (P>0.05) was observed in the clinical chemistry and hematological parameters following oral 
administrations of SKEO at the doses of 0.2 and 0.3 ml/kg for 14 days.  
Conclusion: The results showed the potential of SKEO as a natural source for the production of new prophylactic agent 
for use in toxoplasmosis.  
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Introduction 
 
Toxoplasma gondii as an intracellular protozoan parasite can infect a broad spectrum of warm-blooded 
animals as well as humans (Hill and Dubey 2002). Human infection to toxoplasmosis occurs through three ways: eating 
oocysts with food, eating raw meat containing tissue cysts and also from mother to fetus (Robert-Gangneux and Darde 
2012; Mahmoudvand et al., 2016a). Although, toxoplasmosis cause no symptoms in healthy humans; but in 
immunocompromised individuals, for example persons with HIV/AIDS, receiving an organ transplant, toxoplasmosis 
may result in severe manifestations, such as myocarditis, and encephalitis (Derouin and Pelloux 2008; Signorini et al., 
2007). To date, chemotherapy of T. gondii with the combination of pyrimethamine and sulfadiazine, plus folic acid, is 
the preferred option to treat toxoplasmosis (Montoya and Liesenfeld 2004). Reviews have reported that side-effects of 
pyrimethamine are: osteoporosis, liver toxicity, as well as teratogenic effects, particularly in patients with immune 
deficiency syndromes (Georgiev 1994; Parsil 2009). Sulfadiazine, a sulfonamide antibiotic, is also applied along with 
pyrimethamine to treat T. gondii infection. However, some adverse side-effects, including faintness, lethargy, 
headache, and vomiting, limit its use (Georgiev 1994; Parsil 2009). 
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The use of plant medicines is typically widespread to treat a number of diseases such as infectious ones as well 
as keep public health (Rocha et al., 2005; Ezatpour et al., 2015). Since the last few decades, natural products have 
played a key role in the search for new drugs to treat a variety of human diseases (Cowan 1999). Satureja khuzestanica 
Jamzad is a medicinal plant which commonly grows in Western Iran (Hadian et al., 2011). In traditional medicine, S. 
khuzestanica has been widely used as an algesic, anti-diarrhea, and antiseptic (Hajhashemi et al., 2010; Hadian et al., 
2011).  Moreover, recent studies have reported several therapeutic properties of the plant, such as antioxidant, anti-
inflammatory, hepatoprotective and antimicrobial properties (Amanlou et al., 2004; Ghazanfari et al., 2006; Sanchez de  
Rojas et al., 1999; Sadeghi-Nejad et al., 2010; and Safarnavadeh et al., 2011). Previous studies have demonstrated that 
the principal components of the S. khuzestanica essential oil (SKEO) in greatest species are to be phenols, carvacrol, 
thymol, p-cymene, β-caryo - phyllene, linalool, monoterpenes, sesquiterpenes, and alcohols (Farsam et al., 2004; 
Hadian et al., 2011). However, chemical composition of essential oils is depended on some agents such as the 
geographical origin of the variety and collection time (Saedi Dezaki et al., 2015; Yesil Celiktas et al., 2007). Here we 
aimed to access the chemical composition and prophylactic effects of SKEO in mice model of acute toxoplasmosis.  
 
Materials and Methods 
Plant materials 
 
Plant materials (aerial parts) of S. khuzestanica were collected from rural regions of Lorestan province, West 
of Iran, in May 2015. They were identified by a botanist of the Botany Department of Lorestan University, Lorestan, 
Iran. Voucher specimens have been deposited in the herbarium of Research Center for Agriculture Sciences, Lorestan 
University of Medical Sciences, Khorramabad, Iran (LF 2522). 
 
Isolation of essential oil 
 
Room air-dried plant sample was subjected to hydro-distillation for 3 h using an all-glass Clevenger type 
apparatus. The obtained essential oil was dried over anhydrous sodium sulfate and stored in darkness at 4°C until 
testing (Mahmoudvand et al., 2016c). 
 
Gas chromatography/mass spectrometry (GC/MS) analysis of essential oil 
GC analysis 
 
GC analysis was carried out by Hewlett-Packard 6890 (Hewlett-Packard, Palo Alto, CA) with a HP-5MS 
column (30 m×0.25mm, film thickness 0.25 mm). The column temperature was maintained at 55°C for 3 min, 
programmed to 180°C in the rate of 5°C per min, and kept constant at 220°C for 5 min. Injector and interface 
temperatures were 220 and 290°C, respectively. The flow rate of helium as carrier gas was (1 mL/min C.F). The 
percentages were calculated by the electronic integration of FID peak areas without using response factor correction. 
Linear retention indices for all the components were determined by the co-injection of the samples with a solution 
containing homologous series of C8-C22 n-alkanes. 
 
GC/MS analysis 
 
GC/MS analysis was performed using a Thermoquest–Finnigan gas chromatograph equipped with fused silica 
capillary DB-5 column (30 m×0.25mm, film thickness 0.25 mm) coupled with a TRACE mass (CAS, Manchester, 
UK). Helium was used as the carrier gas with an ionization voltage of 70 eV. Ion source and interface temperatures 
were 220 and 290°C, respectively. Mass range was from 40 to 400u. Temperature program of the oven was as 
mentioned above for the GC. 
 
Identifying the essential oil components 
 
The components of the essential oils were determined by evaluating their relative retention time and mass 
spectra with the standards, Wiley 2001 library data of the GC/MS system, or those reported in the literature data 
(Adams 2004). 
 
Parasite 
 
T. gondii (RH strain) tachyzoites was kindly obtained from the Parasitology Laboratory at the Department of 
Parasitology and Mycology, Tehran University of Medical Sciences, Tehran, Iran. Parasites (1×104) were inoculated in 
the mice, and after 72 h, tachyzoites were provided by repeated flushing of the peritoneal cavity by Phosphate Buffered 
Saline (PBS). Tachyzoites were then harvested and recovered with PBS and used in the experiments. To establish 
animal model of acute toxoplasmosis each group of mice was inoculated intraperitonealy (IP) with 1×104 tachyzoite of 
T. gondii. 
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Animals 
 
Forty-eight male NMRI mice (6–8 weeks old) weighing from 20 to 25 g were obtained from the Pasteur 
Institute, Tehran, Iran. Animals were housed in a colony room with a 12:12h light/ dark cycle at 21 ± 2°C and were 
handled according to standard protocols for the use of laboratory animals.  
 
 
 
 
Prophylactic effects of SKEO 
 
To evaluate the prophylactic effects of SKEO, mice were divided into four groups (of 12 mice per each 
group). (i) non-treated group, (ii) mice treated with olive oil once a day for two weeks, (iii) mice treated with SKEO at 
the dose of 0.2 ml/kg once a day for two weeks, (iv) and mice orally treated with SKEO at the dose of 0.3 ml/kg once a 
day for two weeks. After 24h. (fifteenth day) mice in the groups of two-four were infected intraperitonealy with 104 
tachyzoite of T. gondii, RH strain. Then, the following parameters were performed to determine the prophylactic effects 
of SKEO against acute toxoplasmosis induced by RH strain of T. gondii in mice model. 
 
Mortality rate  
 
The mortality rate was determined according to the following formula: 
MR=  
 
Parasite burden 
 
To evaluate the parasite burden in the infected mice, the mean number of T. gondii tachyzoites in the 
peritoneal fluid of mice were calculated in 10 high power field (HPF) and then the mean number of tachyzoites 10/HPF 
was estimated. Finally, the mean number of tachyzoites in each subgroup of infected mice was calculated (Tavakoli 
Kareshk et al., 2015). 
 
Ethical statement 
 
The present investigation was performed in line with the National Institutes of Health. The present study was 
admired by the Committee on the Ethics of Animal Experiments of the Lorestan University of Medical Science, Iran 
(no. 93/110). 
 
Statistical analysis 
 
Data analysis was carried out using SPSS statistical package version 17.0 (SPSS Inc., Chicago, IL, USA). 
One-way ANOVA with Tukey’s post-hoc test was used to assess differences between experimental groups. In addition, 
P<0.05 was considered statistically significant. 
 
Results 
GC/MS analysis of SKEO 
 
Table 1 shows the findings by GC/MS analysis of SKEO. Sixteen compounds were identified, indicating 
99.6% of the total oil. The main components were carvacrol (78.8%), thymol (7.5%), and beta-bisabolene (1.2%) 
(Table 1). 
 
Prophylactic effects of SKEO 
 
Figure1 shows the mortality rate of infected mice in tested groups. The mortality rate of mice in control group 
was 100% in the fifth day. Moreover, 100% mortality was observed in the 7th and 8th days after oral administration of 
SKEO at the concentrations of 0.2 and 0.3 ml/kg, respectively; which demonstrated that SKEO significantly increased 
the time of death in the infected mice by acute toxoplasmosis (Fig. 1). 
The results obtained demonstrated that the mean number of tachyzoites was 260 × 104 and 189 × 104 for 
infected mice treated with 0.2 and 0.3 ml/kg respectively, while in control group, the mean number of tachyzoites was 
390 × 104 parasite. The results show that the difference in mortality rate between the SKEO at the concentration of 0.2 
and 0.3 ml/kg and the control group was statistically significant (P<0.05). The difference in mean number of 
tachyzoites between infected mice received SKEO and the control group was also statistically significant (P<0.05) 
(Fig. 2). 
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Table 1. Essential oil composition of S. khuzestanica identified by GC-MS 
No Components RT % Composition 
1.  beta-Myrcene 9.47 0.2 
2.  1-Phellandrene 9.89 0.2 
3.  α-Terpinene 10.31 0.2 
4.  ρ -Cymene 10.41 0.8 
5.  Limonene 10.73 0.2 
6.  γ- Terpinene 11.69 0.3 
7.  α- Terpineolene 12.67 0.2 
8.  Linalool 12.88 0.5 
9.  Borneol 14.85 0.5 
10.  Terpinene-4-ol 15.27 0.9 
11.  α- Terpineolene 15.86 0.3 
12.  Thymol 18.53 7.5 
13.  Carvacrol 18.96 78.8 
14.  Carvone 19.16 7.6 
15.  beta.-Bisabolene 24.57 1.2 
16.  Cis-.Alpha.-Bisabolene 25.32 0.2 
 Total  99.6 
a Retention time 
 
 
 
 
Figure 1: Prophylactic effects of Satureja khuzistanica essential oil on the mortality rate of infected mice with acute 
toxoplasmosis 
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Figure 2: Effects of various concentrations of Satureja khuzistanica essential oil on the mean number of tachyzoites of 
infected mice with acute toxoplasmosis 
 
Discussion 
  
Based on the World Health Organization (WHO) reports, more than half of the world used herbal medicine for 
their early medical supplies.  Traditionally, humans trust in plant medicines because of possessing high efficacy, low 
toxicity and high availability for treatment of a wide spectrum of diseases such as infections ones (Rocha et al., 2005). 
The present investigation was designed to explore the prophylactic activity on infected mice with acute toxoplasmosis. 
According to the obtained findings, oral administration of SKEO for two weeks at the doses of 0.2 and 0.3 
ml/kg exhibited considerable prophylactic effects against acute toxoplasmosis in mice. The results also revealed that 
SKEO at the doses of 0.2 and 0.3ml/kg significantly decreased the mean of tachyzoites burden in infected mice. 
Regarding prophylactic effects of herbal medicines, Tavakoli Karesh et al (2015) have demonstrated the capability of 
Bunium persicum essential oil as a possible resource for the development of new prophylactic drug for toxoplasmosis. 
Previous studies have reported antiparasitic, antibacterial and antifungal effects of S. khuzestanica. Some researchers 
also demonstrated the antifungal effect of S. khuzestanicaon against several fungal pathogenic strains (Sadeghi-Nejad 
et al., 2010). Zomorodian et al. (2015) have reported potent antimicrobial effects of SKEO against pathogens causing 
oral infections including Candida spp. Staphylococcus spp. and Entrococcus spp. in in vitro models. Regarding 
antiparasitic effects of S. khuzestanica, in a study conducted by Kheirandish et al (2011) it has been reported that 
SKEO significantly improved cutaneous leishmaniasis in BALB/c mice infected by Leishmania major. Moreover, 
Moazeni et al (2012) have studied the scolicidal effect of S. khuzistanica essential oil on Echinococcus granulosus 
protoscoleces; they demonstrated that S. khuzistanica essential oil has a large amount of carvacrol, and that it can be 
considered as a proper scolicidal agent. 
In this study, we found that the main components of SKEO are carvacrol (78.8%), thymol (7.5%), and beta-
Bisabolene (1.2%), respectively. Consistent with our study, Kheirandish et al. (2011) and Farsam et al. (2004) have 
demonstrated that the main component of SKEO is carvacrol. However, it should be mentioned that chemical 
composition essential oil is related to species, weather, collection time, and morphological parts used (Saedi Dezaki et 
al., 2015; Yesil Celiktas et al., 2007). Carvacrol is a monoterpenoid phenol which possesses antiseptic, antibacterial, 
antifungal, as well as anti-nociceptive and anti-inflammatory properties (Hajhashemi et al., 2002; Ultee et al., 2002). 
Additionally, Monzote et al. (2014), revealed that carvacrol had significant leishmanicidal activity with the IC50 value 
of 15.3 mg/mL for promastigotes, and 13.6mg/mL for the amastigote forms of L. amazonensis. Thus, phytoconstituents 
of SKEO might be answerable for its prophylactic effects, although their precise method of action is not entirely clear. 
However, regarding the mechanism of action of phenolic compounds, such as carvacrol and thymol, it has been shown 
that these compounds are proton exchangers, thus dropping the gradient through the cytoplasmic wall. They cause 
break down of proton-motrice force and reduction of the ATP pool, leading finally to cell death (Arfa et al., 2006). 
In the case of toxicity effects of S. khuzistanica, Abdollahi et al. (2003) demonstrated that oral administration 
of S. khuzistanica essential oil to rats produced a noticeable antioxidant, antidiabetic, antihyperlipidemic effects with no 
severe complications. The obtained results of the current study revealed the considerable prophylactic efficacy of the 
SKEO in mice model of acute T. gondii infection. Moreover, these outcomes offer the scientific confirmation that 
natural plants could be applied in traditional remedy to prevent and treat parasitic infections. Nevertheless, additional 
investigations are required to assess the precise effects of SKEO and its immunomodulatory effect on acute 
toxoplasmosis. 
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